top of page
Executive Spotlights

Aquyre Biosciences Announces Appointment of Gregory Bowles as President and CEO

Weston, MA, December 5, 2023 (Business Wire) -- Aquyre Biosciences, Inc. has announced the appointment of Gregory Bowles as President, Chief Executive Officer, and member of the Board of Directors. This leadership change is intended to propel the company to the next stage with the development and launch of the Van Gogh system, an advanced phase-contrast microscope optimized for "specimen adequacy assessment," a crucial step in cancer diagnosis.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Kommentare


Life Science Headlines
bottom of page